A 61-year-old female is hospitalized for COPD exacerbation. She is obese and not able to ambulate very far on her own. Upon discharge, the physician wants to send her home on heparin to reduce the risk of deep vein thrombosis. Why would the physician choose a low-molecular-weight heparin (LMWH) instead of unfractionated heparin (UFH)?